| Literature DB >> 34764408 |
Eyun Song1, Min Jeong Park1, Jung A Kim1, Eun Roh1, Ji Hee Yu1, Nam Hoon Kim1, Hye Jin Yoo1, Ji A Seo1, Sin Gon Kim1, Nan Hee Kim1, Sei Hyun Baik1, Kyung Mook Choi2.
Abstract
Possible links between periodontitis and various cardiometabolic and autoimmune diseases have been advocated on the basis of chronic inflammation or oxidative stress. However, the association between periodontitis and thyroid dysfunction is under-researched. Participants without previous thyroid disease or ongoing thyroid-related medication were included from a nationwide population-level survey. Participants were categorized into tertiles of thyroid stimulating hormone (TSH) levels (first tertile < 1.76 mIU/L; second tertile 1.76-2.83 mIU/L; third tertile > 2.83 mIU/L), and periodontal condition was assessed using the Community Periodontal Index. Of the total of 5468 participants, 1423 had periodontitis (26%). A significant difference in the weighted prevalence of periodontitis according to TSH tertiles was observed, with the highest prevalence in the first tertile (26.5%) and the lowest prevalence in the third tertile (20.9%, p = 0.003). Subjects in the first TSH tertile had higher odds for periodontitis than those in the third tertile (OR 1.36, 95% CI 1.10-1.68; p for trend = 0.005) after adjusting for covariates. This association was consistent across subgroups and within sensitivity analyses among subjects without specific factors affecting thyroid function or diseases reported to be related to periodontitis. The present study demonstrated that low TSH levels were associated with significantly higher odds for periodontitis.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34764408 PMCID: PMC8586139 DOI: 10.1038/s41598-021-01682-9
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Flow chart of participants included in the study. Abbreviations: CPI: Community Periodontal Index; KHANES, Korea National Health and Nutrition Examination Survey; TSH: thyroid-stimulating hormone.
Baseline characteristics of study participants according to TSH tertiles.
| TSH | ||||
|---|---|---|---|---|
| 1st tertile (n = 1796) | 2nd tertile (n = 1811) | 3rd tertile (n = 1861) | ||
| Serum TSH level (range) | < 1.76 | 1.76–2.83 | ≥ 2.83 | |
| Age (years), median (IQR) | 41.0 (28.0–55.0) | 41.0 (26.0–56.0) | 41.0 (25.0–56.0) | 0.375 |
| Sex (female), n (%) | 773 (37.1%) | 828 (38.2%) | 1002 (46.6%) | < 0.001 |
| Body mass index (kg/m2), median (IQR) | 23.3 (21.0–25.8) | 23.4 (21.0–25.6) | 23.2 (21.1–25.6) | 0.877 |
| Smoking (yes), n (%) | 833 (50.4%) | 691 (42.1%) | 593 (36.4%) | < 0.001 |
| Alcohol (yes), n (%) | 1556 (88.1%) | 1516 (86.0%) | 1532 (85.3%) | 0.001 |
| Exercise (yes), n (%) | 1571 (88.3%) | 1608 (90.0%) | 1662 (89.8%) | 0.201 |
| Fasting glucose (mg/dL), median (IQR) | 93.0 (87.0–101.0) | 93.0 (88.0–101.0) | 93.0 (88.0–100.0) | 0.290 |
| Systolic blood pressure (mmHg), median (IQR) | 113.0 (104.0–124.0) | 114.0 (105.0–125.0) | 113.0 (105.0–124.0) | 0.230 |
| Total cholesterol (mg/dL), median (IQR) | 182.0 (159.0–206.0) | 181.0 (158.0–205.0) | 183.0 (160.0–208.0) | 0.14 |
| eGFR (mL/min), median (IQR) | 93.0 (83.0–105.1) | 91.1 (80.2–103.9) | 91.3 (80.5–105.7) | 0.003 |
| AST (U/L), median (IQR) | 19.0 (16.0–24.0) | 20.0 (16.0–23.0) | 19.0 (16.0–24.0) | 0.808 |
| ALT (U/L), median (IQR) | 17.0 (12.0–24.0) | 17.0 (12.0–24.0) | 16.0 (12.0–24.0) | 0.199 |
| Log-transformed urine iodine, median (IQR) | 2.4 (2.1–2.7) | 2.5 (2.2–2.8) | 2.6 (2.3–2.9) | < 0.001 |
| Anti-TPO antibody (yes), n (%) | 59 (3.1%) | 60 (2.7%) | 149 (7.9%) | < 0.001 |
| Periodontitis (yes), n (%) | 513 (26.5%) | 471 (23.1%) | 439 (20.9%) | 0.003 |
AST aspartate transaminase, ALT alanine transaminase, eGFR estimated glomerular filtration rate, IQR interqurtile range, TPO thyroid peroxidase, TSH thyroid-stimulating hormone.
Figure 2Weighted prevalence of periodontitis according to TSH tertiles in (A) all participants, (B) males, and (C) females. Abbreviations: PO, periodontitis; TSH: thyroid stimulating hormone.
Associations between periodontitis and serum TSH levels.
| 1st tertile | 2nd tertile | 3rd tertile | ||
|---|---|---|---|---|
| Model 1 | 1.34 (1.11–1.63) | 1.09 (0.91–1.31) | 1.0 (Ref) | 0.003 |
| Model 2 | 1.39 (1.14–1.71) | 1.15 (0.95–1.39) | 1.0 (Ref) | 0.001 |
| Model 3 | 1.36 (1.10–1.68) | 1.16 (0.96–1.41) | 1.0 (Ref) | 0.005 |
Model 1: adjusted for age and sex.
Model 2: adjusted for age, sex, BMI, smoking, alcohol consumption, exercise, fasting glucose, SBP, total cholesterol, eGFR, AST, and ALT.
Model 3: adjusted for age, sex, BMI, smoking, alcohol consumption, exercise, fasting glucose, SBP, total cholesterol, eGFR, AST, ALT, log urine iodine, and TPOAb.
CI confidence interval, OR odds ratio, BMI body mass index, SBP systolic blood pressure, eGFR estimated glomerular filtration ratio, AST aspartate transaminase, ALT alanine transaminase, TPO thyroid peroxidase, TSH thyroid-stimulating hormone.
Figure 3Multivariable adjusted associations between periodontitis and serum TSH levels among participant subgroups. ORs for the 1st tertile group in reference to the 3rd tertile group are presented with 95% CIs. Abbreviations: CI, confidence interval; TSH, thyroid-stimulating hormone.